Deep learning to estimate durable clinical benefit and prognosis from patients with non-small cell lung cancer treated with PD-1/PD-L1 blockade

Overview of attention for article published in Frontiers in immunology, November 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 8 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 15 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 59,729 followers.

Deep learning to estimate durable clinical benefit and prognosis from patients with non-small cell lung cancer treated with PD-1/PD-L1 blockade https://t.co/dmWL1WpP0e https://t.co/glV0g8FPkH

28 Nov 2022

Reply Repost Favourite

#DeepLearning to estimate durable clinical benefit and prognosis from patients with non-small cell lung #Cancer treated with PD-1/PD-L1 blockade - PubMed https://t.co/8dyJyThSmZ H/T: @biodomtomi https://t.co/CCioBDGygP

25 Nov 2022

Reply Repost Favourite

Deep learning to estimate durable clinical benefit and prognosis from patients with non-small cell lung cancer treated with PD-1/PD-L1 blockade #pdl1 #lungcancer https://t.co/avXJS8zopm

25 Nov 2022

Reply Repost Favourite

Deep learning to estimate durable clinical benefit and prognosis from patients with non-small cell... https://t.co/yXrWOZewcW #ai #ml #dl

24 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.